Last Posted: May 18, 2019
- A new era: artificial intelligence and machine learning in prostate cancer.
Goldenberg S Larry et al. Nature reviews. Urology 2019 May - The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status.
Magi-Galluzzi Cristina et al. Urology 2018 Nov 121132-138 - Effectiveness of interventions to identify and manage patients with familial cancer risk in primary care: a systematic review.
Lee Siang Ing et al. Journal of community genetics 2019 May - Artificial intelligence at the intersection of pathology and radiology in prostate cancer.
Harmon Stephnie A et al. Diagnostic and interventional radiology (Ankara, Turkey) 2019 May 25(3) 183-188 - Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
Sonpavde Guru et al. Cancer 2019 May 125(9) 1459-1469 - Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.
Yu Hongjie et al. The Prostate 2019 Apr - Genomic Classifiers for Treatment Selection in Newly Diagnosed Prostate Cancer.
Fine Noam David et al. BJU international 2019 May - Lynch syndrome and urologic malignancies: a contemporary review.
Lim Amy et al. Current opinion in urology 2019 Apr - Genomic correlates of clinical outcome in advanced prostate cancer.
Abida Wassim et al. Proceedings of the National Academy of Sciences of the United States of America 2019 May - Multicenter optimization and validation of a 2-gene mRNA urine test for detection of clinically significant prostate cancer prior to initial prostate biopsy.
Haese Alexander et al. The Journal of urology 2019 Apr 101097JU0000000000000293
No hay comentarios:
Publicar un comentario